{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:01:24Z","timestamp":1791662484589,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Ultrasonics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10396-025-01581-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T02:10:05Z","timestamp":1759975805000},"page":"169-177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Constructing a predictive model for anti-M\u00fcllerian hormone levels in reproductive-age women based on transvaginal three-dimensional ultrasound"],"prefix":"10.1007","volume":"53","author":[{"given":"Xing","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"1581_CR1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","volume":"114","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2020","unstructured":"Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114:1151\u20137.","journal-title":"Fertil Steril"},{"key":"1581_CR2","first-page":"411","volume":"9","author":"R Amanvermez","year":"2016","unstructured":"Amanvermez R, Tosun M. An update on ovarian aging and ovarian reserve tests. Int J Fertil Steril. 2016;9:411\u20135.","journal-title":"Int J Fertil Steril"},{"key":"1581_CR3","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s11357-023-00768-8","volume":"45","author":"MB Cavalcante","year":"2023","unstructured":"Cavalcante MB, Sampaio OGM, C\u00e2mara FEA, et al. Ovarian aging in humans: potential strategies for extending reproductive lifespan. Geroscience. 2023;45:2121\u201333.","journal-title":"Geroscience"},{"key":"1581_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/138920112799361972","volume":"13","author":"A La Marca","year":"2012","unstructured":"La Marca A, Argento C, Sighinolfi G, et al. Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol. 2012;13:398\u2013408.","journal-title":"Curr Pharm Biotechnol"},{"key":"1581_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.fertnstert.2015.09.033","volume":"105","author":"G Lambert-Messerlian","year":"2016","unstructured":"Lambert-Messerlian G, Plante B, Eklund EE, et al. Levels of antim\u00fcllerian hormone in serum during the normal menstrual cycle. Fertil Steril. 2016;105:208-13.e1.","journal-title":"Fertil Steril"},{"key":"1581_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrendo.2011.224","volume":"8","author":"JA Visser","year":"2012","unstructured":"Visser JA, Schipper I, Laven JS, et al. Anti-M\u00fcllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331\u201341.","journal-title":"Nat Rev Endocrinol"},{"key":"1581_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","volume":"31","author":"L Webber","year":"2016","unstructured":"Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926\u201337.","journal-title":"Hum Reprod"},{"key":"1581_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060809","volume":"8","author":"R Cannarella","year":"2019","unstructured":"Cannarella R, Arato I, Condorelli RA, et al. Effects of insulin on porcine neonatal Sertoli cell responsiveness to FSH in vitro. J Clin Med. 2019;8:809.","journal-title":"J Clin Med"},{"key":"1581_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","volume":"31","author":"R Fleming","year":"2015","unstructured":"Fleming R, Seifer DB, Frattarelli JL, et al. Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone. Reprod Biomed Online. 2015;31:486\u201396.","journal-title":"Reprod Biomed Online"},{"key":"1581_CR10","volume":"14","author":"S Sinha","year":"2022","unstructured":"Sinha S, Sharan A, Sinha S. Anti-mullerian hormone as a marker of ovarian reserve and function. Cureus. 2022;14:e29214.","journal-title":"Cureus"},{"key":"1581_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.672890","volume":"9","author":"SJ Chon","year":"2021","unstructured":"Chon SJ, Umair Z, Yoon MS. Premature ovarian insufficiency: past, present, and future. Front Cell Dev Biol. 2021;9:672890.","journal-title":"Front Cell Dev Biol"},{"key":"1581_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2174\/1570161117666190122101611","volume":"17","author":"S Tsiligiannis","year":"2019","unstructured":"Tsiligiannis S, Panay N, Stevenson JC. Premature ovarian insufficiency and long-term health consequences. Curr Vasc Pharmacol. 2019;17:604\u20139.","journal-title":"Curr Vasc Pharmacol"},{"key":"1581_CR13","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1159\/000495895","volume":"51","author":"X Nie","year":"2018","unstructured":"Nie X, Dai Y, Zheng Y, et al. Establishment of a mouse model of premature ovarian failure using consecutive superovulation. Cell Physiol Biochem. 2018;51:2341\u201358.","journal-title":"Cell Physiol Biochem"},{"key":"1581_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12522-010-0051-8","volume":"9","author":"M Murai","year":"2010","unstructured":"Murai M, Takatori E, Omi H, et al. Anti-M\u03cbllerian hormone and 3D-power Doppler histogram: markers of ovarian function with in vitro fertilization treatment. Reprod Med Biol. 2010;9:151\u201361.","journal-title":"Reprod Med Biol"},{"key":"1581_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","volume":"95","author":"CH Kim","year":"2011","unstructured":"Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril. 2011;95:679\u201383.","journal-title":"Fertil Steril"},{"key":"1581_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2147\/IJGM.S25639","volume":"4","author":"S Parco","year":"2011","unstructured":"Parco S, Novelli C, Vascotto F, et al. Serum anti-M\u00fcllerian hormone as a predictive marker of polycystic ovarian syndrome. Int J Gen Med. 2011;4:759\u201363.","journal-title":"Int J Gen Med"},{"key":"1581_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5653\/cerm.2011.38.2.93","volume":"38","author":"JH Yoo","year":"2011","unstructured":"Yoo JH, Kim HO, Cha SW, et al. Age specific serum anti-M\u00fcllerian hormone levels in 1298 Korean women with regular menstruation. Clin Exp Reprod Med. 2011;38:93\u20137.","journal-title":"Clin Exp Reprod Med"},{"key":"1581_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/09513590.2015.1102879","volume":"32","author":"A La Marca","year":"2016","unstructured":"La Marca A, Ferraretti AP, Palermo R, et al. The use of ovarian reserve markers in IVF clinical practice: a national consensus. Gynecol Endocrinol. 2016;32:1\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1581_CR19","volume":"2022","author":"J Wu","year":"2022","unstructured":"Wu J, Zhu X, He J, et al. Clinical value of three-dimensional transvaginal ultrasound in diagnosis of endometrial receptivity and ovarian function in patients with infertility. Comput Math Methods Med. 2022;2022:8438131.","journal-title":"Comput Math Methods Med"},{"key":"1581_CR20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1080\/14767058.2016.1199670","volume":"30","author":"S Karakus","year":"2017","unstructured":"Karakus S, Yildiz C, Aydin H, et al. Value of in situ ovarian volume measured during cesarean delivery to assess the potential of diminished ovarian reserve. J Matern Fetal Neonatal Med. 2017;30:1016\u201322.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1581_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/humupd\/dmu062","volume":"21","author":"S Iliodromiti","year":"2015","unstructured":"Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-M\u00fcllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update. 2015;21:698\u2013710.","journal-title":"Hum Reprod Update"},{"key":"1581_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","volume":"18","author":"P Yang","year":"2020","unstructured":"Yang P, Wu R, Zhang H. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2020;18:76.","journal-title":"Reprod Biol Endocrinol"},{"key":"1581_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"SL Broer","year":"2013","unstructured":"Broer SL, D\u00f3lleman M, van Disseldorp J, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril. 2013;100:420\u20139.","journal-title":"Fertil Steril"},{"key":"1581_CR24","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20:124\u201340.","journal-title":"Hum Reprod Update"},{"key":"1581_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12958-017-0314-x","volume":"15","author":"PA Peres Fagundes","year":"2017","unstructured":"Peres Fagundes PA, Chapon R, Olsen PR, et al. Evaluation of three-dimensional SonoAVC ultrasound for antral follicle count in infertile women: its agreement with conventional two-dimensional ultrasound and serum levels of anti-M\u00fcllerian hormone. Reprod Biol Endocrinol. 2017;15:96.","journal-title":"Reprod Biol Endocrinol"},{"key":"1581_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/0284185116676656","author":"M Nylander","year":"2017","unstructured":"Nylander M, Fr\u00f8ssing S, Bjerre AH, et al. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-M\u00fcllerian hormone. Acta Radiol. 2017. https:\/\/doi.org\/10.1177\/0284185116676656.","journal-title":"Acta Radiol"},{"key":"1581_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ogc.2019.08.001","volume":"46","author":"S Campbell","year":"2019","unstructured":"Campbell S. Ultrasound Evaluation in Female Infertility: part 1, the Ovary and the Follicle. Obstet Gynecol Clin North Am. 2019;46:683\u201396.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1581_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/uog.7505","volume":"35","author":"S Deb","year":"2010","unstructured":"Deb S, Campbell BK, Clewes JS, et al. Quantitative analysis of antral follicle number and size: a comparison of two-dimensional and automated three-dimensional ultrasound techniques. Ultrasound Obstet Gynecol. 2010;35:354\u201360.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1581_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13048-015-0149-z","volume":"8","author":"R Venturella","year":"2015","unstructured":"Venturella R, Lico D, Sarica A, et al. Ovage: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3d-ultrasonographic parameters. J Ovarian Res. 2015;8:21.","journal-title":"J Ovarian Res"},{"key":"1581_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370\u201385.","journal-title":"Hum Reprod Update"},{"key":"1581_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/ajo.12366","volume":"55","author":"K Tremellen","year":"2015","unstructured":"Tremellen K, Zander-Fox D. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan. Aust N Z J Obstet Gynaecol. 2015;55:384\u20139.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1581_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.fertnstert.2019.09.029","volume":"113","author":"Y Wakimoto","year":"2020","unstructured":"Wakimoto Y, Pors SE, Cadenas J, et al. The precise ovarian volume is significantly associated with serum concentrations of antim\u00fcllerian hormone, the luteinizing hormone\/follicle-stimulating hormone ratio, and total testosterone. Fertil Steril. 2020;113:453\u20139.","journal-title":"Fertil Steril"},{"key":"1581_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2147\/IJWH.S329082","volume":"13","author":"NSV Le","year":"2021","unstructured":"Le NSV, Le MT, Nguyen ND, et al. A cross-sectional study on potential ovarian volume and related factors in women with polycystic ovary syndrome from infertile couples. Int J Womens Health. 2021;13:793\u2013801.","journal-title":"Int J Womens Health"},{"key":"1581_CR34","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10390","volume":"8","author":"S Umarsingh","year":"2020","unstructured":"Umarsingh S, Adam JK, Krishna SBN. The relationship between anti-M\u00fcllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART). PeerJ. 2020;8:e10390.","journal-title":"PeerJ"},{"key":"1581_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/09513590.2014.964639","volume":"31","author":"M Ferrario","year":"2015","unstructured":"Ferrario M, Secomandi R, Cappato M, et al. Ovarian and adrenal androgens may be useful markers to predict oocyte competence and embryo development in older women. Gynecol Endocrinol. 2015;31:125\u201330.","journal-title":"Gynecol Endocrinol"},{"key":"1581_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10815-022-02449-5","volume":"39","author":"P Arvis","year":"2022","unstructured":"Arvis P, Rongi\u00e8res C, Pirrello O, et al. Reliability of AMH and AFC measurements and their correlation: a large multicenter study. J Assist Reprod Genet. 2022;39:1045\u201353.","journal-title":"J Assist Reprod Genet"},{"key":"1581_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/09513590.2017.1291614","volume":"33","author":"J Subir\u00e1","year":"2017","unstructured":"Subir\u00e1 J, Alberola-Rubio J, N\u00fa\u00f1ez MJ, et al. Inter-cycle and inter-observer variability of the antral follicle count in routine clinical practice. Gynecol Endocrinol. 2017;33:515\u20138.","journal-title":"Gynecol Endocrinol"}],"container-title":["Journal of Medical Ultrasonics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-025-01581-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10396-025-01581-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10396-025-01581-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:53:24Z","timestamp":1776621204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10396-025-01581-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1007\/s10396-025-01581-w","relation":{},"ISSN":["1346-4523","1613-2254"],"issn-type":[{"value":"1346-4523","type":"print"},{"value":"1613-2254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest are declared by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants were informed about the study and provided written consent. This study was approved by the Ethics Committee of Hangzhou Traditional Chinese Medicine Hospital (Ethics Approval No. 2020LH005).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}